Bullish
Edgewise Therapeutics Reports First Quarter 2026 Financial Results and Advances Clinical Programs in Muscular Dystrophy and Cardiovascular Indications
Edgewise Therapeutics reported its first-quarter 2026 financial results and provided updates on its clinical programs. The company highlighted positiv...